Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

What is the risk of mortality with calcium channel blockers?

0
Posted

What is the risk of mortality with calcium channel blockers?

0

There has been a lot of publicity recently concerning the risk of mortality with calcium blockers. This was initiated after a presentation of data which compared relative mortality of beta-blockers and calcium blockers. This scientific study was seized upon by the press and appeared on nearly every front page in the country. However, the study which I mentioned does not come to definite conclusions. Rather, it is the type of study which prompts others studies to see if some of the data is true and accurate. These studies are still in progress. However, review by the Food and Drug Administration has recently stated that there appears to be no excess risk with calcium channel blockers-with one exception. Nifedipine(brand name procardia) in the short acting dose has been seen to cause problems in some individuals. As a result, this drug is rarely used. Curiously, the long acting or slow release form of the drug does not appear to have these same problems. I know of no physician who has al

0

There has been a lot of publicity recently concerning the risk of mortality with calcium blockers. This was initiated after a presentation of data which compared relative mortality of beta-blockers and calcium blockers. This scientific study was seized upon by the press and appeared on nearly every front page in the country. However, the study which I mentioned does not come to definite conclusions. Rather, it is the type of study which prompts others studies to see if some of the data is true and accurate. These studies are still in progress. However, review by the Food and Drug Administration has recently stated that there appears to be no excess risk with calcium channel blockers-with one exception. Nifedipine(brand name procardia) in the short acting dose has been seen to cause problems in some individuals. As a result, this drug is rarely used. Curiously, the long acting or slow release form of the drug does not appear to have these same problems. I know of no physician who has al

Related Questions

What is your question?

*Sadly, we had to bring back ads too. Hopefully more targeted.